Role of Carbonic Anhydrase in Cerebral Ischemia and Carbonic Anhydrase Inhibitors as Putative Protective Agents. 2021

Irene Bulli, and Ilaria Dettori, and Elisabetta Coppi, and Federica Cherchi, and Martina Venturini, and Lorenzo Di Cesare Mannelli, and Carla Ghelardini, and Alessio Nocentini, and Claudiu T Supuran, and Anna Maria Pugliese, and Felicita Pedata
Department of Neuroscience, Psycology, Drug Research and Child Health (NEUROFARBA), Section of Pharmacology and Toxicology, University of Florence, 50139 Florence, Italy.

Ischemic stroke is a leading cause of death and disability worldwide. The only pharmacological treatment available to date for cerebral ischemia is tissue plasminogen activator (t-PA) and the search for successful therapeutic strategies still remains a major challenge. The loss of cerebral blood flow leads to reduced oxygen and glucose supply and a subsequent switch to the glycolytic pathway, which leads to tissue acidification. Carbonic anhydrase (CA, EC 4.2.1.1) is the enzyme responsible for converting carbon dioxide into a protons and bicarbonate, thus contributing to pH regulation and metabolism, with many CA isoforms present in the brain. Recently, numerous studies have shed light on several classes of carbonic anhydrase inhibitor (CAI) as possible new pharmacological agents for the management of brain ischemia. In the present review we summarized pharmacological, preclinical and clinical findings regarding the role of CAIs in strokes and we discuss their potential protective mechanisms.

UI MeSH Term Description Entries
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D002245 Carbon Dioxide A colorless, odorless gas that can be formed by the body and is necessary for the respiration cycle of plants and animals. Carbonic Anhydride,Anhydride, Carbonic,Dioxide, Carbon
D002256 Carbonic Anhydrases A family of zinc-containing enzymes that catalyze the reversible hydration of carbon dioxide. They play an important role in the transport of CARBON DIOXIDE from the tissues to the LUNG. EC 4.2.1.1. Carbonate Dehydratase,Carbonic Anhydrase,Anhydrases, Carbonic,Dehydratase, Carbonate
D002257 Carbonic Anhydrase Inhibitors A class of compounds that reduces the secretion of H+ ions by the proximal kidney tubule through inhibition of CARBONIC ANHYDRASES. Carbonate Dehydratase Inhibitor,Carbonate Dehydratase Inhibitors,Carbonic Anhydrase Inhibitor,Carboxyanhydrase Inhibitor,Carboxyanhydrase Inhibitors,Anhydrase Inhibitor, Carbonic,Dehydratase Inhibitor, Carbonate,Inhibitor, Carbonate Dehydratase,Inhibitor, Carbonic Anhydrase,Inhibitor, Carboxyanhydrase,Inhibitors, Carbonate Dehydratase,Inhibitors, Carbonic Anhydrase,Inhibitors, Carboxyanhydrase
D002545 Brain Ischemia Localized reduction of blood flow to brain tissue due to arterial obstruction or systemic hypoperfusion. This frequently occurs in conjunction with brain hypoxia (HYPOXIA, BRAIN). Prolonged ischemia is associated with BRAIN INFARCTION. Cerebral Ischemia,Ischemic Encephalopathy,Encephalopathy, Ischemic,Ischemia, Cerebral,Brain Ischemias,Cerebral Ischemias,Ischemia, Brain,Ischemias, Cerebral,Ischemic Encephalopathies
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000083242 Ischemic Stroke Stroke due to BRAIN ISCHEMIA resulting in interruption or reduction of blood flow to a part of the brain. When obstruction is due to a BLOOD CLOT formed within in a cerebral blood vessel it is a thrombotic stroke. When obstruction is formed elsewhere and moved to block a cerebral blood vessel (see CEREBRAL EMBOLISM) it is referred to as embolic stroke. Wake-up stroke refers to ischemic stroke occurring during sleep while cryptogenic stroke refers to ischemic stroke of unknown origin. Acute Ischemic Stroke,Cryptogenic Embolism Stroke,Cryptogenic Ischemic Stroke,Cryptogenic Stroke,Ischaemic Stroke,Wake-up Stroke,Acute Ischemic Strokes,Cryptogenic Embolism Strokes,Cryptogenic Ischemic Strokes,Cryptogenic Strokes,Embolism Stroke, Cryptogenic,Ischaemic Strokes,Ischemic Stroke, Acute,Ischemic Stroke, Cryptogenic,Ischemic Strokes,Stroke, Acute Ischemic,Stroke, Cryptogenic,Stroke, Cryptogenic Embolism,Stroke, Cryptogenic Ischemic,Stroke, Ischaemic,Stroke, Ischemic,Stroke, Wake-up,Wake up Stroke,Wake-up Strokes
D001639 Bicarbonates Inorganic salts that contain the -HCO3 radical. They are an important factor in determining the pH of the blood and the concentration of bicarbonate ions is regulated by the kidney. Levels in the blood are an index of the alkali reserve or buffering capacity. Bicarbonate,Bicarbonate Ions,Hydrogen Carbonates,Bicarbonate Ion,Carbonic Acid Ions,Hydrogen Carbonate,Carbonate, Hydrogen,Carbonates, Hydrogen,Ion, Bicarbonate,Ions, Bicarbonate,Ions, Carbonic Acid
D013449 Sulfonamides A group of compounds that contain the structure SO2NH2. Sulfonamide,Sulfonamide Mixture,Sulfonamide Mixtures,Mixture, Sulfonamide,Mixtures, Sulfonamide
D020244 Infarction, Middle Cerebral Artery NECROSIS occurring in the MIDDLE CEREBRAL ARTERY distribution system which brings blood to the entire lateral aspects of each CEREBRAL HEMISPHERE. Clinical signs include impaired cognition; APHASIA; AGRAPHIA; weak and numbness in the face and arms, contralaterally or bilaterally depending on the infarction. Cerebral Infarction, Middle Cerebral Artery,Embolic Infarction, Middle Cerebral Artery,MCA Infarct,Middle Cerebral Artery Embolus,Middle Cerebral Artery Infarction,Stroke, Middle Cerebral Artery,Thrombotic Infarction, Middle Cerebral Artery,Embolus, Middle Cerebral Artery,Left Middle Cerebral Artery Infarction,MCA Infarction,Middle Cerebral Artery Circulation Infarction,Middle Cerebral Artery Embolic Infarction,Middle Cerebral Artery Occlusion,Middle Cerebral Artery Stroke,Middle Cerebral Artery Syndrome,Middle Cerebral Artery Thrombosis,Middle Cerebral Artery Thrombotic Infarction,Occlusion, Middle Cerebral Artery,Right Middle Cerebral Artery Infarction,Thrombosis, Middle Cerebral Artery,Infarct, MCA,Infarcts, MCA,MCA Infarcts

Related Publications

Irene Bulli, and Ilaria Dettori, and Elisabetta Coppi, and Federica Cherchi, and Martina Venturini, and Lorenzo Di Cesare Mannelli, and Carla Ghelardini, and Alessio Nocentini, and Claudiu T Supuran, and Anna Maria Pugliese, and Felicita Pedata
January 2007, Current topics in medicinal chemistry,
Irene Bulli, and Ilaria Dettori, and Elisabetta Coppi, and Federica Cherchi, and Martina Venturini, and Lorenzo Di Cesare Mannelli, and Carla Ghelardini, and Alessio Nocentini, and Claudiu T Supuran, and Anna Maria Pugliese, and Felicita Pedata
August 1968, The British journal of ophthalmology,
Irene Bulli, and Ilaria Dettori, and Elisabetta Coppi, and Federica Cherchi, and Martina Venturini, and Lorenzo Di Cesare Mannelli, and Carla Ghelardini, and Alessio Nocentini, and Claudiu T Supuran, and Anna Maria Pugliese, and Felicita Pedata
March 2001, Bioorganic & medicinal chemistry,
Irene Bulli, and Ilaria Dettori, and Elisabetta Coppi, and Federica Cherchi, and Martina Venturini, and Lorenzo Di Cesare Mannelli, and Carla Ghelardini, and Alessio Nocentini, and Claudiu T Supuran, and Anna Maria Pugliese, and Felicita Pedata
February 2014, Archives of physiology and biochemistry,
Irene Bulli, and Ilaria Dettori, and Elisabetta Coppi, and Federica Cherchi, and Martina Venturini, and Lorenzo Di Cesare Mannelli, and Carla Ghelardini, and Alessio Nocentini, and Claudiu T Supuran, and Anna Maria Pugliese, and Felicita Pedata
May 2021, Clinical science (London, England : 1979),
Irene Bulli, and Ilaria Dettori, and Elisabetta Coppi, and Federica Cherchi, and Martina Venturini, and Lorenzo Di Cesare Mannelli, and Carla Ghelardini, and Alessio Nocentini, and Claudiu T Supuran, and Anna Maria Pugliese, and Felicita Pedata
January 2008, Current pharmaceutical design,
Irene Bulli, and Ilaria Dettori, and Elisabetta Coppi, and Federica Cherchi, and Martina Venturini, and Lorenzo Di Cesare Mannelli, and Carla Ghelardini, and Alessio Nocentini, and Claudiu T Supuran, and Anna Maria Pugliese, and Felicita Pedata
October 2023, Current medicinal chemistry,
Irene Bulli, and Ilaria Dettori, and Elisabetta Coppi, and Federica Cherchi, and Martina Venturini, and Lorenzo Di Cesare Mannelli, and Carla Ghelardini, and Alessio Nocentini, and Claudiu T Supuran, and Anna Maria Pugliese, and Felicita Pedata
August 2016, ChemMedChem,
Irene Bulli, and Ilaria Dettori, and Elisabetta Coppi, and Federica Cherchi, and Martina Venturini, and Lorenzo Di Cesare Mannelli, and Carla Ghelardini, and Alessio Nocentini, and Claudiu T Supuran, and Anna Maria Pugliese, and Felicita Pedata
August 2021, International journal of molecular sciences,
Irene Bulli, and Ilaria Dettori, and Elisabetta Coppi, and Federica Cherchi, and Martina Venturini, and Lorenzo Di Cesare Mannelli, and Carla Ghelardini, and Alessio Nocentini, and Claudiu T Supuran, and Anna Maria Pugliese, and Felicita Pedata
May 1963, Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica,
Copied contents to your clipboard!